What is he best known for?
The fields of study he is best known for:
- Gene
- Enzyme
- Internal medicine
His primary areas of study are Cell biology, Thrombin, Apoptosis, Programmed cell death and Internal medicine.
His Cell biology research is multidisciplinary, relying on both Downregulation and upregulation, Neurodegeneration and Biochemistry.
His Thrombin study combines topics in areas such as Proteases, Serpin, Protease, Receptor and Molecular biology.
His Apoptosis research is multidisciplinary, incorporating elements of Spinal cord injury and Immunology.
His Internal medicine research includes elements of Endocrinology and Cardiology.
His Endocrinology research is multidisciplinary, incorporating perspectives in Amyotrophic lateral sclerosis and Severity of illness.
His most cited work include:
- Xeroderma pigmentosum. An inherited diseases with sun sensitivity, multiple cutaneous neoplasms, and abnormal DNA repair. (646 citations)
- Effect of recombinant human insulin-like growth factor-I on progression of ALS A placebo-controlled study (318 citations)
- Minocycline neuroprotects, reduces microgliosis, and inhibits caspase protease expression early after spinal cord injury. (182 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Biochemistry, Cell biology, Internal medicine, Thrombin and Skeletal muscle.
His study in Cell biology is interdisciplinary in nature, drawing from both Cell culture, Apoptosis, Programmed cell death, Neurodegeneration and Tissue transglutaminase.
His research investigates the connection with Programmed cell death and areas like Spinal cord which intersect with concerns in Downregulation and upregulation.
His biological study spans a wide range of topics, including Gastroenterology and Endocrinology.
The various areas that Barry W. Festoff examines in his Thrombin study include Proteases, Molecular biology, Serpin and Receptor.
The Skeletal muscle study combines topics in areas such as Myocyte, Neuromuscular junction and Denervation.
He most often published in these fields:
- Biochemistry (51.61%)
- Cell biology (42.86%)
- Internal medicine (47.47%)
What were the highlights of his more recent work (between 2000-2019)?
- Cell biology (42.86%)
- Thrombin (41.94%)
- Neuroscience (20.28%)
In recent papers he was focusing on the following fields of study:
Barry W. Festoff mostly deals with Cell biology, Thrombin, Neuroscience, Receptor and Neurodegeneration.
Barry W. Festoff interconnects Thrombin receptor, Biochemistry, Tissue transglutaminase, Messenger RNA and Gene isoform in the investigation of issues within Cell biology.
His work deals with themes such as Apoptosis, Signal transduction, Neuroprotection and p38 mitogen-activated protein kinases, which intersect with Thrombin.
His studies in Neuroprotection integrate themes in fields like Caspase and Spinal cord injury, Spinal cord.
In his research on the topic of Neurodegeneration, Motor neuron is strongly related with Central nervous system.
His research in Immunology intersects with topics in Gastroenterology, Internal medicine and Blood–brain barrier.
Between 2000 and 2019, his most popular works were:
- Minocycline neuroprotects, reduces microgliosis, and inhibits caspase protease expression early after spinal cord injury. (182 citations)
- Participation of protease‐activated receptor‐1 in thrombin‐induced microglial activation (147 citations)
- Microglial activation, increased TNF and SERT expression in the prefrontal cortex define stress-altered behaviour in mice susceptible to anhedonia (115 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Enzyme
- Internal medicine
Barry W. Festoff spends much of his time researching Receptor, Cell biology, Neurodegeneration, Neuroscience and Thrombin.
The concepts of his Receptor study are interwoven with issues in Hippocampal formation and Pathogenesis.
His Cell biology study integrates concerns from other disciplines, such as Tissue transglutaminase and Gene isoform.
His studies deal with areas such as Gene family and Alternative splicing, Biochemistry, Gene, Messenger RNA as well as Neurodegeneration.
His research on Thrombin often connects related topics like Microglia.
The study of Internal medicine and Endocrinology are components of his Tumor necrosis factor alpha research.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
